Last year, British Columbia became the first province to introduce a mandatory biosimilar switching program for non-medical reasons.
access to new medicine
April 12, 2023
1:00AM
May 13, 2021
1:00AM
April 15, 2020
11:26AM
The biopharmaceutical industry is uniquely prepared to combat COVID-19.
March 18, 2019
3:03PM
Unfortunately, the federal government’s track record of creating reliable and accurate data systems is not good.
February 21, 2019
10:03AM
Developing and testing new drugs costs a lot of money.
January 24, 2019
1:00AM
November 1, 2018
11:01AM
Nobel laureate Paul Romer’s key new insight was that human capital can produce ideas.